Board Meeting-Appointment of Director
We wish to inform you that based on the recommendation of Nomination and Remuneration Committee and the Board of Directors at its meeting held today (May 15, 2018) has approved the appointment of Mr. Santanu Mukherjee (DIN: 07716452) as an Independent, Non-Executive Director of the Company for a term of 5 years and subject to the approval of the members at the ensuing Annual General Meeting of the Company. 1) Notification Of Audited Standalone & Consolidated Financial Results For The Quarter & Financial Year Ended 31St March 2018 2) Closure Of Register Of Members & Share Transfer Books And AGM
1) Notification of audited standalone & consolidated Financial Results for the quarter & financial year ended 31st March 2018 2) Closure of Register of Members & Share Transfer Books and AGM 3) We wish to inform you that based on the recommendation of Nomination and Remuneration Committee and the Board of Directors at its meeting held today (May 15, 2018) has approved the appointment of Mr. Santanu Mukherjee (DIN: 07716452) as an Independent,... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to above subject, please find enclosed herewith an invitation for conducting the conference call for investors on Wednesday, May 16, 2018 at 12:00 noon IST to discuss the Audited Financial Results for the Q4 Financial Year 2018, to be declared on 15th May, 2018 Suven secures product patents in Australia, Eurasia and Europe
Suven Life Sciences has been granted a product patent each by Australia, Eurasia and Europe corresponding to a new chemical entity (NCE) for the tre Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences secures Product Patents in Australia, Eurasia and Europe Suven's Pashamylaram unit completes USFDA inspection
Suven Life Sciences' Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.The facility has undergone Board Meeting-Closure of Trading Window
With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Board Meeting of our Company will be held on Tuesday, the 15th May, 2018 at 11:30 a.m. at the Registered Office, SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad - 500034 of the Company, to consider, among other things, inter alia, and take on record the following matters:... Announcement under Regulation 30 (LODR)-Press Release / Media Release
SUVEN's Pashamylaram's Unit Successfully completes US FDA Inspection USFDA Inspection
We would like to inform our shareholders through exchanges about the information appeared in media about FDA inspection in our Pashamylaram, Medak unit during Feb 2018. US FDA during the inspection observed that there are procedures that followed on certain aspects are deficient in nature. Since these observations are procedural in nature, we have already revised our standard operating procedures (SOP's) as a corrective action and trained employees...